Skip to main content

Advertisement

Log in

SEOM clinical guidelines for diagnosis and treatment of testicular seminoma (2010)

  • Clinical Guides in Oncology
  • Published:
Clinical and Translational Oncology Aims and scope Submit manuscript

Abstract

Testicular cancer represents the most common malignancy in males aged 15–34 years. Nearly 40% of cases correspond to seminomas and three quarters of them are diagnosed with stage I disease. After orchiectomy, clinical staging should include serial tumour marker assays (alphafetoprotein must be negative), abdominal CT scan and chest X-ray films. Patients with stage I disease can be followed-up (active surveillance) or receive adjuvant carboplatin chemotherapy (those with rete testis invasion or non-compliant with follow-up). More advanced disease (stage II and III) and patients with extragonadal seminomas should receive chemotherapy (3–4 courses of BEP) according to IGCCCG risk classification. Residual lesions must be managed by surveillance if they are smaller than 3 cm, while those larger than 3 cm should be evaluated by means of PET. Surgery is only recommended in PET-positive lesions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. American Joint Committee on Cancer (2010) Cancer staging manual, 7th edn. Springer Science and Business Media, Chicago

    Google Scholar 

  2. International Germ Cell Cancer Collaborative Group (1997) International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. J Clin Oncol 15:594–603

    Google Scholar 

  3. Krege S, Beyer J, Souchon R et al (2008) European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): parts I&II. Eur Urol 53:478–513

    Article  PubMed  Google Scholar 

  4. Oliver RT, Mason MD, Mead GM et al (2005) Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial. Lancet 366:293–300

    Article  PubMed  CAS  Google Scholar 

  5. Warde P, Specht L, Horwich A et al (2002) Prognostic factors for relapse in stage I seminoma managed by surveillance: a pooled analysis. J Clin Oncol 20:4448–4452

    Article  PubMed  Google Scholar 

  6. Schmoll H-J, Jordan K, Huddart R et al (2010) Testicular seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 21[Suppl 5]:v140–v146

    Article  PubMed  Google Scholar 

  7. (2010) National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology. Testicular Cancer. V.2.2010. www.nccn.org

  8. Grupo Germinal (2009) Protocolo multidisciplinario de diagnóstico y tratamiento de los tumores germinales 2009. www.grupogerminal.org

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jorge Aparicio.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Aparicio, J., Sastre, J., Germà, J.R. et al. SEOM clinical guidelines for diagnosis and treatment of testicular seminoma (2010). Clin Transl Oncol 13, 560–564 (2011). https://doi.org/10.1007/s12094-011-0697-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12094-011-0697-7

Keywords

Navigation